These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 11454888

  • 1. Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients.
    Kushner BH, Yeung HW, Larson SM, Kramer K, Cheung NK.
    J Clin Oncol; 2001 Jul 15; 19(14):3397-405. PubMed ID: 11454888
    [Abstract] [Full Text] [Related]

  • 2. 18F-FDG PET/CT and 123I-metaiodobenzylguanidine imaging in high-risk neuroblastoma: diagnostic comparison and survival analysis.
    Papathanasiou ND, Gaze MN, Sullivan K, Aldridge M, Waddington W, Almuhaideb A, Bomanji JB.
    J Nucl Med; 2011 Apr 15; 52(4):519-25. PubMed ID: 21421719
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic value of 18F-FDG PET/CT in paediatric neuroblastoma: comparison with 131I-MIBG scintigraphy.
    Dhull VS, Sharma P, Patel C, Kundu P, Agarwala S, Bakhshi S, Bhatnagar V, Bal C, Kumar R.
    Nucl Med Commun; 2015 Oct 15; 36(10):1007-13. PubMed ID: 26049371
    [Abstract] [Full Text] [Related]

  • 4. Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastoma.
    Taggart DR, Han MM, Quach A, Groshen S, Ye W, Villablanca JG, Jackson HA, Mari Aparici C, Carlson D, Maris J, Hawkins R, Matthay KK.
    J Clin Oncol; 2009 Nov 10; 27(32):5343-9. PubMed ID: 19805691
    [Abstract] [Full Text] [Related]

  • 5. 123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.
    Bleeker G, Tytgat GA, Adam JA, Caron HN, Kremer LC, Hooft L, van Dalen EC.
    Cochrane Database Syst Rev; 2015 Sep 29; 2015(9):CD009263. PubMed ID: 26417712
    [Abstract] [Full Text] [Related]

  • 6. Impact of metaiodobenzylguanidine scintigraphy on assessing response of high-risk neuroblastoma to dose-intensive induction chemotherapy.
    Kushner BH, Yeh SD, Kramer K, Larson SM, Cheung NK.
    J Clin Oncol; 2003 Mar 15; 21(6):1082-6. PubMed ID: 12637474
    [Abstract] [Full Text] [Related]

  • 7. 123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma.
    Sharp SE, Shulkin BL, Gelfand MJ, Salisbury S, Furman WL.
    J Nucl Med; 2009 Aug 15; 50(8):1237-43. PubMed ID: 19617326
    [Abstract] [Full Text] [Related]

  • 8. Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting.
    Park JR, Bagatell R, Cohn SL, Pearson AD, Villablanca JG, Berthold F, Burchill S, Boubaker A, McHugh K, Nuchtern JG, London WB, Seibel NL, Lindwasser OW, Maris JM, Brock P, Schleiermacher G, Ladenstein R, Matthay KK, Valteau-Couanet D.
    J Clin Oncol; 2017 Aug 01; 35(22):2580-2587. PubMed ID: 28471719
    [Abstract] [Full Text] [Related]

  • 9. PET/CT imaging in neuroblastoma.
    Piccardo A, Lopci E, Conte M, Foppiani L, Garaventa A, Cabria M, Villavecchia G, Fanti S, Cistaro A.
    Q J Nucl Med Mol Imaging; 2013 Mar 01; 57(1):29-39. PubMed ID: 23474633
    [Abstract] [Full Text] [Related]

  • 10. Abnormal FDG and MIBG Activity in the Bones in a Patient With Neuroblastoma Without Detectable Primary Tumor.
    Zhang W, Zhuang H, Servaes S.
    Clin Nucl Med; 2016 Aug 01; 41(8):632-3. PubMed ID: 26825196
    [Abstract] [Full Text] [Related]

  • 11. Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.
    Claudiani F, Stimamiglio P, Bertolazzi L, Cabria M, Conte M, Villavecchia GP, Garaventa A, Lanino E, De Bernardi B, Scopinaro G.
    Q J Nucl Med; 1995 Dec 01; 39(4 Suppl 1):21-4. PubMed ID: 9002744
    [Abstract] [Full Text] [Related]

  • 12. The role of 131 iodine-metaiodobenzylguanidine scanning in the correlative imaging of patients with neuroblastoma.
    Andrich MP, Shalaby-Rana E, Movassaghi N, Majd M.
    Pediatrics; 1996 Feb 01; 97(2):246-50. PubMed ID: 8584386
    [Abstract] [Full Text] [Related]

  • 13. Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy.
    Shulkin BL, Hutchinson RJ, Castle VP, Yanik GA, Shapiro B, Sisson JC.
    Radiology; 1996 Jun 01; 199(3):743-50. PubMed ID: 8637999
    [Abstract] [Full Text] [Related]

  • 14. Iodine-131-metaiodobenzylguanidine and bone scintigraphy for the detection of neuroblastoma.
    Shulkin BL, Shapiro B, Hutchinson RJ.
    J Nucl Med; 1992 Oct 01; 33(10):1735-40. PubMed ID: 1403138
    [Abstract] [Full Text] [Related]

  • 15. Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer.
    Morris MJ, Akhurst T, Osman I, Nunez R, Macapinlac H, Siedlecki K, Verbel D, Schwartz L, Larson SM, Scher HI.
    Urology; 2002 Jun 01; 59(6):913-8. PubMed ID: 12031380
    [Abstract] [Full Text] [Related]

  • 16. Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer.
    Nuñez R, Macapinlac HA, Yeung HW, Akhurst T, Cai S, Osman I, Gonen M, Riedel E, Scher HI, Larson SM.
    J Nucl Med; 2002 Jan 01; 43(1):46-55. PubMed ID: 11801702
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the diagnostic accuracy of 99 m-Tc-MDP bone scintigraphy and 18 F-FDG PET/CT for the detection of skeletal metastases.
    Chang CY, Gill CM, Joseph Simeone F, Taneja AK, Huang AJ, Torriani M, Bredella MA.
    Acta Radiol; 2016 Jan 01; 57(1):58-65. PubMed ID: 25533313
    [Abstract] [Full Text] [Related]

  • 18. (18)F-FDG PET as a single imaging modality in pediatric neuroblastoma: comparison with abdomen CT and bone scintigraphy.
    Choi YJ, Hwang HS, Kim HJ, Jeong YH, Cho A, Lee JH, Yun M, Lee JD, Kang WJ.
    Ann Nucl Med; 2014 May 01; 28(4):304-13. PubMed ID: 24481823
    [Abstract] [Full Text] [Related]

  • 19. ¹²³I-MIBG scintigraphy/SPECT versus ¹⁸F-FDG PET in paediatric neuroblastoma.
    Melzer HI, Coppenrath E, Schmid I, Albert MH, von Schweinitz D, Tudball C, Bartenstein P, Pfluger T.
    Eur J Nucl Med Mol Imaging; 2011 Sep 01; 38(9):1648-58. PubMed ID: 21617976
    [Abstract] [Full Text] [Related]

  • 20. The new international neuroblastoma response criteria.
    Orr KE, McHugh K.
    Pediatr Radiol; 2019 Oct 01; 49(11):1433-1440. PubMed ID: 31620844
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.